drugset / Trial / NCT00515736
Impact Of Antioxidant Micronutrients On Intensive Care Unit (ICU) Outcome
RandomizedParallel-groupQuadruple-blindSupportive care
Summary
Critically ill patients are generally exposed to an increased oxidative stress, which is proportional to the severity of their condition. Endogenous antioxidant (AOX) defenses are depleted particularly in those patients with intense inflammatory response. The hypothesis tested is that early I:V: administration of a combination of AOX micronutrient supplements (Se, Zn, Vit C, Vit E, Vit B1) would improve clinical outcome in selected critically ill patients, by reinforcing the endogenous AOX defenses and reducing organ failure.
Timeline
- Start
- 2003-01
- Primary completion
- 2005-12
- Completion
- 2005-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Selenium | Other / unclassified | 270 ug | Intravenous |
| Subject | Thiamine | Other / unclassified | 100 mg | Intravenous |
| Subject | Vitamin C | Other / unclassified | 1.1 g | Intravenous |
| Subject | Vitamin E | Other / unclassified | 300 mg | Intravenous |
| Subject | Zinc - Laboratoire Aguettant, the others generic | Other / unclassified | 30 mg | Intravenous |